Adams D B, Bromberg J S
Department of Surgery, Medical University of South Carolina, Charleston 29425.
Surg Endosc. 1994 Aug;8(8):890-2. doi: 10.1007/BF00843463.
Laparoscopic cholecystectomy is the treatment of choice for symptomatic cholelithiasis. Since its introduction in 1987, this procedure has been employed with increasing frequency as its safety has been documented in numerous studies. Absolute contraindications to laparoscopic cholecystectomy have become relative contraindications, and patients previously felt to be at excessive risk for laparoscopic cholecystectomy are viewed as patients who may benefit from laparoscopic cholecystectomy. The use of this procedure in patients with comorbid medical conditions has the potential to decrease patient morbidity. Patients who have previously undergone solid organ transplantation and require immunosuppressive therapy are a group of patients who may benefit from laparoscopic cholecystectomy. We report four patients who have previously undergone combined renal and pancreas transplantation who underwent successful laparoscopic cholecystectomy.
腹腔镜胆囊切除术是有症状胆结石的首选治疗方法。自1987年引入以来,随着其安全性在众多研究中得到证实,该手术的应用频率越来越高。腹腔镜胆囊切除术的绝对禁忌症已变为相对禁忌症,以前被认为腹腔镜胆囊切除术风险过高的患者现在被视为可能从腹腔镜胆囊切除术获益的患者。在患有合并症的患者中使用该手术有可能降低患者的发病率。先前接受过实体器官移植并需要免疫抑制治疗的患者是可能从腹腔镜胆囊切除术获益的一组患者。我们报告了4例先前接受过肾胰联合移植并成功接受腹腔镜胆囊切除术的患者。